參考文獻：  

[1] Hu J, Gao J, Liu J, et al. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China[J]. Ultrasound in Obstetrics & Gynecology, 2021, 58(4): 529-539.

[2] Chappell L C, Cluver C A, Tong S. Pre-eclampsia[J]. The Lancet, 2021, 398(10297): 341-354.

[3]李春艷,夏卿,龍偉.子癇前期聯(lián)合篩查的研究進(jìn)展[J].現代婦產(chǎn)科進(jìn)展,2022,31(10):779-782.

[4]Spencer K. Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A[J]. British Journal of Obstetrics and Gynaecology, 2001, 108(10): 1043-1046.

[5]Orosz L, Orosz G, Veress L, et al. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary[J]. Journal of biotechnology, 2019, 300: 11-19.

[6]徐曉冬,尚麗新,曲冬穎.孕早期血清胎盤(pán)生長(cháng)因子、妊娠相關(guān)蛋白-A、β-人絨毛膜促性腺激素檢測聯(lián)合子宮動(dòng)脈血流參數對子癇前期預測價(jià)值研究[J].臨床軍醫雜志,2021,49(01):44-46+49.